Washington, DC – The Board of Pharmacy Specialties (BPS) is pleased to announce new officers for the 2019 Board of Directors. 

 

Peter G. Koval, PharmD, BCPS, CPP to Serve as 2019 BPS Chair

Karen M. Gunning, PharmD, BCPS, BCACP to Serve as Chair-Elect

Andrea Iannucci, PharmD, BCOP to Serve as Immediate Past BPS Chair

 

2019 Officers

Peter G. Koval, PharmD, BCPS, CPP will serve as the 2019 BPS Chair. Koval is currently the Associate Professor of Clinical Education, University of North Carolina Chapel Hill Eshelman School of Pharmacy. His clinical pharmacy position is in collaboration with the Greensboro Area Health Education Center (AHEC), and the Moses Cone Family Practice Residency Program. Dr. Koval received his Doctor of Pharmacy degree from Campbell University School of Pharmacy. He completed a Pharmacy Practice Residency at the Cone Health System in Greensboro, North Carolina, then completed a primary care specialty residency in St. Louis, Missouri. He previously served on the BPS Ambulatory Care Pharmacy Specialty Council.

 

Karen M. Gunning, PharmD, BCPS, BCACP will serve as the 2019 BPS Chair-elect and will assume the BPS Chairmanship in 2020. Gunning currently holds appointments as Associate Dean of Community Engagement, Professor of Pharmacotherapy, and Adjunct Professor of Family and Preventive Medicine at the University of Utah College of Pharmacy and School of Medicine. Her clinical practice is at the University of Utah Sugarhouse Family Health Center, a residency training site for the University of Utah Family Medicine Residency Program. She provides direct patient care services for chronic disease management as a part of an interprofessional team, teaches pharmacy, physician assistant and medical students, and is the program director of the University of Utah Healthcare PGY-2 Ambulatory Care Pharmacy Residency. She is a past Chair of the BPS Pharmacotherapy Specialty Council.

 

Andrea Iannucci, PharmD, BCOP will serve as the 2019 Immediate Past BPS Chair. Dr. Iannucci is currently Assistant Chief Pharmacist, Oncology and Investigational Drugs Services at the University of California, Davis Medical Center and a Clinical Professor with the UCSF School of Pharmacy and UCDMC School of Medicine. She is the Director of the PGY2 Oncology Specialty Residency at UCDMC. Andrea completed her Doctor of Pharmacy degree at the University of California in San Francisco. She completed her Pharmacy Practice Residency at UCSF, and an Oncology Pharmacy Specialty Residency at MD Anderson Cancer Center. She has served as an appointed member and chair of the Oncology Specialty Council of the Board of Pharmacy Specialties.

 

For Information on the BPS Board of Directors: Click here

 

About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world.


Board Certification through BPS has become recognized as the gold standard for determining which pharmacists are qualified to contribute at advanced practice levels as a result of the rigorous standards mandated by BPS board certification and recertification. Today over 41,000 pharmacists worldwide hold BPS certification.

 

BPS Contact

Alexander Jean-Baptiste

Social Media & Content Marketing Manager

ajeanbaptiste@aphanet.org 

(202) 760-3836